Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Celenys

Celenys
2013 FOUNDED
OOB STATUS
11-20 EMPLOYEES
Liquidation LATEST DEAL TYPE
Description

Developer of hyaluronic acid based scaffolds designed for 3D cell culture. The company's hyaluronic acid based scaffolds are based on 3D study model for oncology and stem cell culture.

Website
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • 75 route de Lyons la forĂȘt
  • 76000 Rouen
  • France

+33 09 00 00 00 00
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Celenys’s full profile, request a free trial.

Celenys Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Bankruptcy: Liquidation 07-Mar-2017 00.000 Completed Bankruptcy: Liquidation
1. Early Stage VC 30-Apr-2014 00.000 00.000 Completed Generating Revenue/Not Profitable
To view this company’s complete deal history including valuation and funding, request access »

Celenys Executive Team (3)

Name Title Board
Seat
Contact
Info
Nicolas Dubois Co-Founder & Chief Executive Officer
Elise Demange Ph.D Co-Founder, President, Chief Scientific Officer and Chairman
Agathe Devaux Ph.D Director, Business Development